12 Best Fundamental Stocks to Buy Now

5. Boston Scientific Corporation (NYSE:BSX)

Number of Hedge Fund Holdings: 92

10-Year Revenue Growth Rate: 8.17%

10-Year Net Income Growth Rate: 20.06%

Boston Scientific Corporation (NYSE:BSX) is a developer, manufacturer, and marketer of medical devices that are used in a range of interventional medical specialties including cardiology, endoscopy, neurology, and urology, among other fields. The company a has diverse portfolio of products and technologies and provides it to healthcare professionals and patients worldwide.

Boston Scientific Corporation (NYSE:BSX) is investing in emerging markets and technologies, such as structural heart and electrophysiology. The company has recently launched its ACURATE Prime platform in Europe, which has shown promising results and has the potential to increase the eligible patient population by approximately 20%. Additionally, Boston Scientific Corporation (NYSE:BSX) is committed to its TAVR program in the US and is working closely with the FDA to determine the most efficient and prudent path forward. The TAVR is a procedure where a doctor replaces a damaged heart valve using a thin tube inserted through an incision in the leg, without needing major open-heart surgery. The company believes that its Prime platform, with its enhanced features and increased radial force, will play a critical role in its future success in the TAVR market.

Boston Scientific Corporation (NYSE:BSX) is also prioritizing the development of its portfolio of imaging and diagnostic technologies, including its IVUS and OCT platforms. The company’s AVVIGO+ system, which utilizes artificial intelligence to aid in the interpretation of IVUS images, has shown significant results and is expected to drive growth in the company’s imaging business. Furthermore, Boston Scientific Corporation (NYSE:BSX) is exploring opportunities to expand its offerings in the field of pulmonary embolism treatment, including its EKOS system, which has demonstrated strong clinical results. By investing in these emerging areas, the company is well-positioned to drive growth and expansion in the coming years.